<DOC>
	<DOCNO>NCT00611923</DOCNO>
	<brief_summary>This study evaluate effectiveness flutamide reduce symptom premenstrual dysphoric disorder .</brief_summary>
	<brief_title>Effectiveness Flutamide Treating Women With Premenstrual Dysphoric Disorder</brief_title>
	<detailed_description>Premenstrual dysphoric disorder ( PMDD ) condition affect 5 % menstruate woman . Women PMDD experience serious emotional physical disturbance , may include depression , tension , irritability , anger , anxiety , sleep appetite problem . Symptoms PMDD directly link menstrual cycle , generally begin latter half cycle end around start next cycle . If leave unmanaged , PMDD may interfere woman 's ability carry normal day-to-day functioning . Current treatment PMDD include medication , psychotherapy , nutritional modification . Flutamide , medication block action testosterone mood-influencing hormone , may helpful alleviate symptom PMDD . This study evaluate effectiveness flutamide reduce symptom premenstrual dysphoric disorder . This two-phase study last total 4 month include 7 study visit . Phase 1 last 2 month include Visits 1 3 . During Phase 1 , participant keep daily record symptom , participate diagnostic interview , undergo medical history review , physical exam , screen laboratory test . Eligible participant enter Phase 2 , treatment phase study . During treatment phase , participant randomly assign take flutamide placebo 2 month . Study visit occur every 2 week include Visits 4 7 . These visit include discussion side effect , symptom rating , laboratory test check pregnancy side effect relate liver function , blood count , blood chemistry . At end treatment flutamide placebo , participant option receive treatment sertraline , antidepressant know effective many woman PMDD . Sertraline give 2 premenstrual week two cycle . If participant already unsuccessfully tried sertraline PMDD treatment , alternative treatment attempt .</detailed_description>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Premenstrual Dysphoric Disorder</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<criteria>Meets DSMIV criterion PMDD history Regular menstrual cycle 25 35 day length year prior study entry Willing use barrier method birth control study sexually active If engage psychotherapy least 3 month study entry , participation allow intensity psychotherapy remain study Normal PAP physical exam , include pelvic exam , within 1 year prior study entry Use oral contraceptive exogenous hormone preparation within 3 month prior study entry Suicide attempt severe suicidal ideation within 2 year prior study entry History psychotic disorder bipolar disorder Substance abuse , except nicotine , within 6 month prior study entry Use pharmacological treatment PMDD symptom ( e.g. , antidepressant , hormone , gonadotropinreleasing hormone agonist , anxiolytic , calcium , herbal preparation , diuretic ) within 3 month prior study entry Daily use psychotropic anticonvulsant medication within 3 month prior study entry Use sleeping pill per week Consumption 50 ounce alcohol per week Pregnant breastfeeding Hepatic , renal , autoimmune , chronic inflammatory disease Seizure disorder Inability read follow instruction English</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Premenstrual Dysphoric Disorder</keyword>
	<keyword>PMDD</keyword>
	<keyword>PMS</keyword>
</DOC>